AIP
BHVN

Ameritas Investment Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Ameritas Investment Partners’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,881
Closed -$737K – 3092
2022
Q3 		$737K Buy
4,881
+209
+4% +$31K 0.03% 634
2022
Q2 		$680K Buy
4,672
+321
+7% +$41K 0.03% 672
2022
Q1 		$516K Hold
4,351
– – 0.02% 795
2021
Q4 		$600K Hold
4,351
– – 0.02% 767
2021
Q3 		$604K Buy
4,351
+115
+3% +$14.4K 0.02% 746
2021
Q2 		$411K Buy
4,236
+206
+5% +$16.7K 0.01% 847
2021
Q1 		$275K Hold
4,030
– – 0.01% 1007
2020
Q4 		$345K Sell
4,030
-138
-3% -$11.7K 0.02% 871
2020
Q3 		$271K Hold
4,168
– – 0.01% 899
2020
Q2 		$305K Buy
4,168
+708
+20% +$37.7K 0.01% 852
2020
Q1 		$118K Hold
3,460
– – 0.01% 1179
2019
Q4 		$188K Buy
3,460
+208
+6% +$10.3K 0.01% 1132
2019
Q3 		$136K Buy
3,252
+418
+15% +$17.7K 0.01% 1285
2019
Q2 		$124K Buy
2,834
+258
+10% +$14.5K 0.01% 1362
2019
Q1 		$133K Buy
2,576
+247
+11% +$10.7K 0.01% 1290
2018
Q4 		$86K Hold
2,329
– – ﹤0.01% 1492
2018
Q3 		$87K Hold
2,329
– – ﹤0.01% 1665
2018
Q2 		$92K Sell
2,329
-353
-13% -$11.2K ﹤0.01% 1605
2018
Q1 		$69K Buy
2,682
+1,804
+205% +$53.9K ﹤0.01% 1732
2017
Q4 		$24K Hold
878
– – ﹤0.01% 2364
2017
Q3 		$31K Hold
878
– – ﹤0.01% 2181
2017
Q2 		$22K Buy
+878
New +$20.2K ﹤0.01% 2410

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Ameritas Investment Partners's BHVN Position: Q4 2022 in Review

Ameritas Investment Partners sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 4,881 shares — an estimated $737K sold.

Ameritas Investment Partners first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $737K in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Ameritas Investment Partners reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 4,881 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $737K.
  • Ameritas Investment Partners first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • Ameritas Investment Partners's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $737K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Ameritas Investment Partners's 13F filing for Q4 2022, filed 13 Feb 2023.